Innovation Pharmaceuticals Inc (IPIX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Innovation Pharmaceuticals Inc (IPIX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010912
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company pipeline products include kevetrin for the treatment of advanced solid tumors and acute myelogenous leukemia; Brilacidin for the treatment of oral mucositis and skin infections; and Prurisol for the treatment of psoriasis.The company works in collaboration with various research institutions across the US and other European countries. Innovation Pharmaceuticals is headquartered in Beverly, Massachusetts, the US.

Innovation Pharmaceuticals Inc (IPIX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Innovation Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Innovation Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Innovation Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Innovation Pharma to Raise USD30 Million in Private Placement of Shares 10
Cellceutix Raises USD16 Million in Private Placement of Common Stock 11
Acquisition 12
Cellceutix Completes Acquisition Of PolyMedix 12
Innovation Pharmaceuticals Inc – Key Competitors 13
Innovation Pharmaceuticals Inc – Key Employees 14
Innovation Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Financial Announcements 16
Feb 16, 2017: Cellceutix Reports on Q2 Fiscal 2017, Prepares for Important Clinical Milestones 16
Nov 14, 2016: Cellceutix Provides Corporate Update and Reports Q1 Fiscal 2017 Financial Results 18
Corporate Communications 22
Sep 16, 2016: Cellceutix Announces Appointment of Vice President for Regulatory Affairs 22
Aug 30, 2016: Cellceutix Further Expands Its Senior Management Team With the Addition of an Industry Veteran 23
Aug 30, 2016: Cellceutix Further Expands Its Senior Managment Team With the Addition of an Industry Veteran 24
Jun 30, 2016: Cellceutix Announces Industry Veteran Arthur P. Bertolino, MD, PhD, MBA Joins Company as President and Chief Medical Officer 25
Mar 08, 2016: Cellceutix Welcomes Dr. Stephen T. Sonis to Its Scientific Advisory Board 26
Legal and Regulatory 27
Jun 07, 2017: Cellceutix Announces Company Name Change to Innovation Pharmaceuticals 27
Other Significant Developments 28
Sep 13, 2016: Cellceutix Provides Business Update and Timeline of Upcoming Milestones 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Innovation Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Innovation Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Innovation Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Innovation Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Innovation Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Innovation Pharma to Raise USD30 Million in Private Placement of Shares 10
Cellceutix Raises USD16 Million in Private Placement of Common Stock 11
Cellceutix Completes Acquisition Of PolyMedix 12
Innovation Pharmaceuticals Inc, Key Competitors 13
Innovation Pharmaceuticals Inc, Key Employees 14

★海外企業調査レポート[Innovation Pharmaceuticals Inc (IPIX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iMedX Inc:医療機器:M&Aディール及び事業提携情報
    Summary iMedX Inc (iMedX) is a provider of medical document management and health information solutions. The company offers transcription services and coding services. It provides iMedX Express web based platforms and iMedX Mobile with DocAssist applications. iMedX’s transcription services comprise …
  • Pegasystems Inc (PEGA):企業の財務・戦略的SWOT分析
    Pegasystems Inc (PEGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ingredion Incorporated:企業の戦略・SWOT・財務情報
    Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report Summary Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Foundation Medicine Inc (FMI)-製薬・医療分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …
  • Seiko Optical Products Co Ltd:企業の戦略的SWOT分析
    Seiko Optical Products Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Centre de Regulacio Genomica-製薬・医療分野:企業M&A・提携分析
    Summary Centre de Regulacio Genomica (CRG) is a biomedical institute that provides research services. The institute provides research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offers faci …
  • Genmab AS (GMAB):企業の財務・戦略的SWOT分析
    Genmab AS (GMAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • JAKKS Pacific, Inc.:企業の戦略・SWOT・財務情報
    JAKKS Pacific, Inc. - Strategy, SWOT and Corporate Finance Report Summary JAKKS Pacific, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Laerdal Medical AS:企業の戦略的SWOT分析
    Laerdal Medical AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Clinical Ink Inc:医療機器:M&Aディール及び事業提携情報
    Summary Clinical Ink Inc (Clinical Ink) is a technology company that offers eSource and patient engagement solutions. The company offers data management solution, monitoring solution, clinical site solution and patient centric solution. It offers SureSource, an eSource platform to capture eSource da …
  • Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a bio pharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematolog …
  • Getty Images Inc:企業の戦略的SWOT分析
    Getty Images Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • ABB Ltd (ABBN)-石油・ガス分野:企業M&A・提携分析
    Summary ABB Ltd. (ABB) is a provider of power and automation technologies. The company provides solutions for secure, energy-efficient generation, transmission and distribution of electricity and for increasing productivity in industrial, commercial and utility operations. ABB’s product and service …
  • Metals X Limited:企業の戦略・SWOT・財務情報
    Metals X Limited - Strategy, SWOT and Corporate Finance Report Summary Metals X Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Societatea Nationala Nuclearelectrica SA (SNN):企業の財務・戦略的SWOT分析
    Societatea Nationala Nuclearelectrica SA (SNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • MediPal Holdings Corp:企業の戦略・SWOT・財務情報
    MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • William Demant Holding AS (WDH)-医療機器分野:企業M&A・提携分析
    Summary William Demant Holding A/S (WDH) develops, manufactures and distributes products and equipment designed to aid people with hearing loss in their individual communication. Its major areas of focus include hearing devices, hearing implants, diagnostic instruments and personal communication dev …
  • Canadian Natural Resources, Ltd.:企業の戦略・SWOT・財務分析
    Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Canadian Natural Resources, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • SGS SA (SGSN):企業の財務・戦略的SWOT分析
    SGS SA (SGSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報
    Summary Theranyx Sarl is a bio technology company that develops novel therapeutic drugs and solutions to treat cancer. The company’s main line business involved in generation of functional antibodies to target GPCRs and ion channel receptors. Its antibodies named as Therabodies has scope in target v …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆